These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 1908431

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of pravastatin sodium, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on very-low-density lipoprotein composition and kinetics in hyperlipidemia associated with experimental nephrosis.
    Hirano T, Komuro F, Furukawa S, Nagano S, Takahashi T.
    Metabolism; 1990 Jun; 39(6):605-9. PubMed ID: 2112675
    [Abstract] [Full Text] [Related]

  • 3. Effect of CS-514 (pravastatin) on VLDL-triglyceride kinetics in rats.
    Yoshino G, Kazumi T, Kasama T, Iwai M, Iwatani I, Matsuba K, Matsushita M, Baba S.
    Atherosclerosis; 1988 Oct; 73(2-3):191-5. PubMed ID: 3142492
    [Abstract] [Full Text] [Related]

  • 4. Influence of pravastatin on hepatic metabolism of cholesterol.
    Hellerstein M.
    N Engl J Med; 1991 Jan 10; 324(2):128. PubMed ID: 1898532
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CS-514 suppresses plasma triglyceride in hypertriglyceridemic subjects without modifying a lipoprotein structural model.
    Yoshino G, Kazumi T, Iwai M, Kasama T, Iwatani I, Matsuba K, Inui A, Uenoyama R, Yokono K, Otsuki M.
    Horm Metab Res; 1987 Oct 10; 19(10):513-4. PubMed ID: 3123351
    [No Abstract] [Full Text] [Related]

  • 11. Plasma lipoproteins in streptozotocin-diabetic rats, after Triton WR-1339 treatment.
    Takahashi K, Murase T, Yamada N, Iwamoto Y, Akanuma Y, Takaku F.
    Horm Metab Res; 1984 Dec 10; 16 Suppl 1():82-4. PubMed ID: 6532938
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Heparin-sepharose 4B affinity chromatography of plasma very low density lipoprotein from streptozotocin-induced diabetic rats.
    Nakai T, Oida K, Tamai T, Kutsumi Y, Kobayashi T, Hayashi T, Takeda R, Yamada S.
    Artery; 1982 Dec 10; 10(3):202-21. PubMed ID: 7103749
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Influence of cholesterol-lowering on plasma membrane lipids and function.
    Lijnen P, Echevaría-Vázquez D, Petrov V.
    Methods Find Exp Clin Pharmacol; 1996 Mar 10; 18(2):123-36. PubMed ID: 8740244
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of rat brain prostaglandin D synthase by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Islam F, Watanabe Y, Hayaishi O.
    Biochem Int; 1990 Nov 10; 22(4):601-5. PubMed ID: 2127671
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.